Agilent Technologies Inc Dossier
|
SectorHealth Care IndustryLife Sciences Tools & Services Beta (adjusted)1.15 Intrinsic Value $134.68median of 6 methods · middle span $123-$143based on filings through 31 Jul 2026 Market Price $172.31Price as of 30 Sep 2026 OvervaluedIntrinsic value is 22% below the market price −50% · IV below pricenear fair value ±15%IV above price · +50% Data confidence Sign in to view data confidence Market Cap $48.6B Enterprise Value $50.5B Shares Outstanding 283M diluted Moat Rating Narrow Next Earnings Date25 Nov 2026 Last ex-dividend30 Jun 2026 All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference. ThesisStreet consensus, scenarios, merits, risks, and invalidation triggers Thesis Summary Agilent entered the final quarter of FY2026 with broad-based growth, higher margins and raised full-year guidance. Q3 core revenue grew 7.3%, all three operating groups expanded revenue, and non-GAAP operating margin reached 28.3%. The quality of the quarter requires normalization because tariff refunds contributed approximately 110 basis points to non-GAAP margin and $0.06 to non-GAAP EPS. This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today. Street view · analyst 12-month targets Low · most bearish analyst$135.00 Mean target$160.11 High · most bullish analyst$185.00 Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026 Scenarios · 12-month scenario targets Bear CaseDownside scenario $135.0019% Demand or execution weakens enough for Q4 core growth to fall below 5.2% or FY2026 non-GAAP EPS to fall below $6.18. The downside would be more consequential if margin performance also deteriorates after removing the Q3 tariff-refund benefit or if acquisition, integration and transformation costs remain elevated. Base CaseCentral scenario $160.1158% Matches the consensus meanAgilent finishes FY2026 within its stated ranges of $7.49-$7.51 billion revenue, 5.8%-6.0% core growth and $6.18-$6.21 non-GAAP EPS, with operating-margin expansion above 130 basis points. Bull CaseUpside scenario $185.0023% Agilent delivers Q4 core growth at or above the 6.2% upper end of guidance, FY2026 non-GAAP EPS at or above $6.21, and margin expansion exceeding 130 basis points. Sustained demand and execution under the Ignite Operating System would support continued earnings momentum after normalizing tariff-refund benefits. Scenarios are anchored to street consensus at the research date, with our probabilities and rationale. Key Investment Merits
Key Investment Risks
All scenarios are estimates and subject to change. Past performance is not indicative of future results. Quality Pillars MembersThis section is available to registered members. Create a free account or sign in to unlock the full breakdown. Explore this dossierValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework. |